1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Key considerations, target product profiles, and research gaps in the application of infrared spectroscopy and artificial intelligence for malaria surveillance and diagnosis

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Studies on the applications of infrared (IR) spectroscopy and machine learning (ML) in public health have increased greatly in recent years. These technologies show enormous potential for measuring key parameters of malaria, a disease that still causes about 250 million cases and 620,000 deaths, annually. Multiple studies have demonstrated that the combination of IR spectroscopy and machine learning (ML) can yield accurate predictions of epidemiologically relevant parameters of malaria in both laboratory and field surveys. Proven applications now include determining the age, species, and blood-feeding histories of mosquito vectors as well as detecting malaria parasite infections in both humans and mosquitoes. As the World Health Organization encourages malaria-endemic countries to improve their surveillance-response strategies, it is crucial to consider whether IR and ML techniques are likely to meet the relevant feasibility and cost-effectiveness requirements—and how best they can be deployed. This paper reviews current applications of IR spectroscopy and ML approaches for investigating malaria indicators in both field surveys and laboratory settings, and identifies key research gaps relevant to these applications. Additionally, the article suggests initial target product profiles (TPPs) that should be considered when developing or testing these technologies for use in low-income settings.

          Related collections

          Most cited references129

          • Record: found
          • Abstract: found
          • Article: not found

          Identification of single specimens of the Anopheles gambiae complex by the polymerase chain reaction.

          A ribosomal DNA-polymerase chain reaction (PCR) method has been developed for species identification of individuals of the five most widespread members of the Anopheles gambiae complex, a group of morphologically indistinguishable sibling mosquito species that includes the major vectors of malaria in Africa. The method, which is based on species-specific nucleotide sequences in the ribosomal DNA intergenic spacers, may be used to identify both species and interspecies hybrids, regardless of life stage, using either extracted DNA or fragments of a specimen. Intact portions of a mosquito as small as an egg or the segment of one leg may be placed directly into the PCR mixture for amplification and analysis. The method uses a cocktail of five 20-base oligonucleotides to identify An. gambiae, An. arabiensis, An. quadriannnulatus, and either An. melas in western Africa or An. melas in eastern and southern Africa.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT).

            The absolute necessity for rational therapy in the face of rampant drug resistance places increasing importance on the accuracy of malaria diagnosis. Giemsa microscopy and rapid diagnostic tests (RDTs) represent the two diagnostics most likely to have the largest impact on malaria control today. These two methods, each with characteristic strengths and limitations, together represent the best hope for accurate diagnosis as a key component of successful malaria control. This review addresses the quality issues with current malaria diagnostics and presents data from recent rapid diagnostic test trials. Reduction of malaria morbidity and drug resistance intensity plus the associated economic loss of these two factors require urgent scaling up of the quality of parasite-based diagnostic methods. An investment in anti-malarial drug development or malaria vaccine development should be accompanied by a parallel commitment to improve diagnostic tools and their availability to people living in malarious areas.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Rapid diagnostic tests for malaria parasites.

              Malaria presents a diagnostic challenge to laboratories in most countries. Endemic malaria, population movements, and travelers all contribute to presenting the laboratory with diagnostic problems for which it may have little expertise available. Drug resistance and genetic variation has altered many accepted morphological appearances of malaria species, and new technology has given an opportunity to review available procedures. Concurrently the World Health Organization has opened a dialogue with scientists, clinicians, and manufacturers on the realistic possibilities for developing accurate, sensitive, and cost-effective rapid diagnostic tests for malaria, capable of detecting 100 parasites/microl from all species and with a semiquantitative measurement for monitoring successful drug treatment. New technology has to be compared with an accepted "gold standard" that makes comparisons of sensitivity and specificity between different methods. The majority of malaria is found in countries where cost-effectiveness is an important factor and ease of performance and training is a major consideration. Most new technology for malaria diagnosis incorporates immunochromatographic capture procedures, with conjugated monoclonal antibodies providing the indicator of infection. Preferred targeted antigens are those which are abundant in all asexual and sexual stages of the parasite and are currently centered on detection of HRP-2 from Plasmodium falciparum and parasite-specific lactate dehydrogenase or Plasmodium aldolase from the parasite glycolytic pathway found in all species. Clinical studies allow effective comparisons between different formats, and the reality of nonmicroscopic diagnoses of malaria is considered.
                Bookmark

                Author and article information

                Contributors
                imshani@ihi.or.tz
                Simon.Babayan@glasgow.ac.uk
                fredros@ihi.or.tz
                Journal
                Malar J
                Malar J
                Malaria Journal
                BioMed Central (London )
                1475-2875
                10 November 2023
                10 November 2023
                2023
                : 22
                : 346
                Affiliations
                [1 ]Ifakara Health Institute, Environmental Health, and Ecological Sciences Department, ( https://ror.org/04js17g72) Morogoro, United Republic of Tanzania
                [2 ]School of Biodiversity, One Health and Veterinary Medicine, University of Glasgow, ( https://ror.org/00vtgdb53) Glasgow, UK
                [3 ]School of Life Sciences and Biotechnology, Nelson Mandela African Institution of Science and Technology, ( https://ror.org/041vsn055) Arusha, United Republic of Tanzania
                [4 ]School of Public Health, The University of the Witwatersrand, ( https://ror.org/03rp50x72) Park Town, South Africa
                [5 ]Department of Medical Biology and Public Health, Institut de Recherche en Sciences de la Santé (IRSS), ( https://ror.org/05m88q091) Bobo-Dioulasso, Burkina Faso
                [6 ]Centro de Investigação em Saúde de Manhiça (CISM), ( https://ror.org/0287jnj14) Maputo, Mozambique
                [7 ]Faculty of Science, School of the Environment, The University of Queensland, ( https://ror.org/00rqy9422) Brisbane, QLD Australia
                [8 ]School of Chemistry, The University of Glasgow, ( https://ror.org/00vtgdb53) Glasgow, G12 8QQ UK
                [9 ]GRID grid.266102.1, ISNI 0000 0001 2297 6811, Malaria Elimination Initiative (MEI), Institute for Global Health Sciences, , University of California, ; San Francisco, USA
                Article
                4780
                10.1186/s12936-023-04780-3
                10638832
                37950315
                011a96d8-ea33-424c-b4df-9f32ad66a7ae
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 4 March 2023
                : 1 November 2023
                Funding
                Funded by: European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program
                Award ID: No. 832703, to KW
                Award Recipient :
                Funded by: Royal Society
                Award ID: Grant No ICA/R1/191238 to SAB University of Glasgow and Ifakara Health Institute
                Funded by: FundRef http://dx.doi.org/10.13039/100000865, Bill and Melinda Gates Foundation;
                Award ID: Grant No. OPP 1217647 to Ifakara Health Institute
                Award Recipient :
                Funded by: Rudolf Geigy Foundation through Swiss Tropical & Public Health Institute
                Award ID: to Ifakara Health Institute
                Award Recipient :
                Categories
                Review
                Custom metadata
                © BioMed Central Ltd., part of Springer Nature 2023

                Infectious disease & Microbiology
                malaria surveillance,infrared spectroscopy,artificial intelligence,machine learning,deep learning,target product profiles

                Comments

                Comment on this article